You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0556 The utility to measure markers of new bone and cartilage metabolism (DKK-1, OPG, CTX-II) in patients treated with tocilizumab: A multicentre, prospective study

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – other biologic treatment
AB0556 The utility to measure markers of new bone and cartilage metabolism (DKK-1, OPG, CTX-II) in patients treated with tocilizumab: A multicentre, prospective study

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014300
Mar 2014700
Apr 2014400
May 2014200
Jun 2014301
Oct 2014200
Nov 2014400
Dec 2014300
Jan 2015200
Feb 2015200
Mar 2015200
Apr 2015300
May 2015300
Jul 2015400
Aug 2015500
Sep 2015200
Nov 2015300
Dec 2015403
Feb 2016200
Mar 2016300
Jun 2016200
Jul 2016200
Aug 2016200
Sep 2016301
Oct 2016400
Nov 2016300
Dec 2016300
Jan 2017500
Feb 2017201
Mar 2017400
Apr 2017100
May 2017500
Jun 2017100
Jul 2017400
Aug 2017400
Sep 20171601
Oct 2017600
Nov 2017600
Dec 2017400
Jan 2018600
Mar 2018400
Apr 2018400
May 20182801
Jun 20183000
Jul 20181000
Aug 2018800
Sep 2018400
Oct 2018200
Nov 2018200
Jan 2019400
Apr 2019200
May 2019600
Jul 2019300
Aug 2019400
Nov 2019101
Feb 2020200
May 2020100
Jun 2020400
Jul 2020400
Sep 20201001
Nov 2020200
Dec 2020400
Jan 2021400
Apr 2021500
Jun 2021400
Jul 2021100
Oct 2021400
Nov 2021201
Dec 2021600
Jan 2022400
Feb 2022600
Mar 2022400
Apr 2022200
May 20221000
Jun 2022600
Jul 20221400
Aug 2022400
Sep 2022400
Oct 2022600
Nov 2022400
Dec 2022800
Jan 2023200
Feb 2023600
Mar 2023200
May 2023200
Jul 2023200
Aug 2023200
Sep 2023600
Oct 2023200
Dec 2023800
Jan 2024200
Feb 2024200
Mar 2024200
Total421011